Salvato in:
Dettagli Bibliografici
Autore principale: Mehak Thakur*, Shabnam, Damini Saini, Neeraj Pooni
Natura: Recurso digital
Lingua:inglese
Pubblicazione: Zenodo 2026
Accesso online:https://doi.org/10.5281/zenodo.20021600
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866901348759371776
author Mehak Thakur*, Shabnam, Damini Saini, Neeraj Pooni
author_facet Mehak Thakur*, Shabnam, Damini Saini, Neeraj Pooni
contents <p>Cancer is one of the major causes of fatality among the world, and traditional chemotherapy is one of the most important methods of treatment. Nevertheless, chemotherapy is frequently associated with extreme side effects, and drug resistance. Ferroptosis is a relatively innovative type of controlled cell death involving lipid peroxidation depends on iron and has become an attractive alternative treatment of cancer. Ferroptosis causing medications get specific to cancer cells because they interfere with redox homeostasis and iron metabolism. This review provides an in-depth comparison between ferroptosis-inducing agents and conventional chemotherapy in terms of their mechanisms, efficacy, advantages, and limitations. It also highlights the possibilities of combination therapies in overcoming chemoresistance and the consequent enhancement of treatment outcomes.</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_20021600
institution Zenodo
language eng
publishDate 2026
publisher Zenodo
record_format zenodo
spellingShingle COMPARATIVE REVIEW OF FERROPTOSIS-INDUCING DRUGS AND TRADITIONAL CHEMOTHERAPY IN CANCER TREATMENT
Mehak Thakur*, Shabnam, Damini Saini, Neeraj Pooni
<p>Cancer is one of the major causes of fatality among the world, and traditional chemotherapy is one of the most important methods of treatment. Nevertheless, chemotherapy is frequently associated with extreme side effects, and drug resistance. Ferroptosis is a relatively innovative type of controlled cell death involving lipid peroxidation depends on iron and has become an attractive alternative treatment of cancer. Ferroptosis causing medications get specific to cancer cells because they interfere with redox homeostasis and iron metabolism. This review provides an in-depth comparison between ferroptosis-inducing agents and conventional chemotherapy in terms of their mechanisms, efficacy, advantages, and limitations. It also highlights the possibilities of combination therapies in overcoming chemoresistance and the consequent enhancement of treatment outcomes.</p>
title COMPARATIVE REVIEW OF FERROPTOSIS-INDUCING DRUGS AND TRADITIONAL CHEMOTHERAPY IN CANCER TREATMENT
url https://doi.org/10.5281/zenodo.20021600